1925MO Regomune study: A phase II study of regorafenib + avelumab in solid tumors. Results of the radioiodine-refractory differentiated thyroid cancer (RR-DTC). - Godbert, Y.; Cousin, S.; Bellera, C.; Guégan, J-P.; Hadoux, J.; Gomez-Roca, C.A.; Cassier, P.; Hescot, S.; Vinches, M.; Cantarel, C.; Palussière, J.; Kind, M.; et al. (Annals of Oncology, 2024)